Moderna

FDA Approves Moderna’s mRNA RSV Vaccine — With No Input From Independent Advisers

The FDA said it bypassed input from the agency’s independent advisers because it didn’t see any “concerns or controversial issues.” Moderna is running at least 11 clinical trials for its new mRNA RSV drug on other demographic groups, including young children, adolescents and healthy adults. by Brenda Baletti, Ph.D. This article was originally published by The

FDA Approves Moderna’s mRNA RSV Vaccine — With No Input From Independent Advisers Read More »

MODERNA’S Rushed Vaccine Trials Revealing Safety Concerns

Rushed Vaccine Trials Revealing Safety Concerns There are more than seventy (70) vaccine candidates in trials around the world. Usually, trials happen quietly, without much public knowledge and little media attention, and safety issues with clinical trial design and data are not revealed until after the release of the product to the public when adverse

MODERNA’S Rushed Vaccine Trials Revealing Safety Concerns Read More »